Selection, teaching and two TSH checks spaced by the drug's half-life make up MN553's closing Unit 10 case analysis for a composite woman with newly diagnosed hypothyroidism. Searches like "mn 553 unit 10 assignment example", "mn553 unit 10 sample" and "mn553 unit 10 example" land here.
Levothyroxine for Overt Primary Hypothyroidism in a 52-Year-Old: Selection, Teaching and Two Follow-Up Visits That Test the Choice
[Student Name]
Purdue University Global
MN553: Advanced Pharmacology
Unit 10 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. No real patient is described, and nothing here is a prescribing instruction.
Case Summary
A composite 52-year-old dental lab technician reports four months of fatigue, feeling cold when others are comfortable, cold hands at work, constipation, dry skin and a 4 kg weight gain over the winter without a change in diet. She weighs 72 kg. Her menstrual periods stopped a year ago. She takes no medications and no supplements at the first visit. Her mother had "an underactive thyroid." Examination shows dry skin, a heart rate of 58 beats per minute, a slightly enlarged, firm, nontender thyroid and delayed relaxation of the ankle reflexes. Laboratory results show a thyroid-stimulating hormone (TSH) of 11.8 mIU/L, a free thyroxine (free T4) below the reference range, and positive thyroid peroxidase (TPO) antibodies. An electrocardiogram shows sinus bradycardia and nothing else. She has no history of heart disease.
Diagnosis
Raised TSH with a low free T4 indicates overt primary hypothyroidism: the thyroid itself is failing, and the pituitary is responding appropriately by increasing TSH. Positive TPO antibodies and a firm goiter are consistent with chronic autoimmune thyroiditis, also called Hashimoto thyroiditis, the most common cause of hypothyroidism in iodine-sufficient regions such as the United States (Chaker et al., 2017). The diagnosis is not in doubt, and this analysis turns to treatment.
Selection: Replacement as a Class
Treatment of hypothyroidism is hormone replacement. Unlike most drug therapy, the goal is not to block or stimulate a pathway but to supply a hormone the body no longer makes in sufficient amounts. Levothyroxine is synthetic T4, identical to the hormone the thyroid secretes. Tissues convert T4 to the active hormone, triiodothyronine (T3), through deiodinase enzymes, so giving T4 allows each tissue to regulate its own supply of T3.
The 2014 American Thyroid Association guideline recommends levothyroxine as the treatment of choice for hypothyroidism (Jonklaas et al., 2014). Liothyronine, synthetic T3, has a short half-life that produces peaks and troughs in T3 levels during the day, and the guideline does not recommend it as routine monotherapy. Desiccated thyroid extracts contain a fixed ratio of T4 to T3 that is higher in T3 than human thyroid secretion, and their content can vary; the guideline does not recommend them as first-line therapy. Levothyroxine provides stable levels with once-daily dosing, low cost and a long record of use.
What would count as success is defined before any tablet is described. Success means a TSH back within the reference range and her symptoms improving over two to three months, and both will be checked against that definition at follow-up.
For a healthy adult of her age without heart disease, the guideline supports starting at full replacement based on weight, about 1.6 mcg per kg per day, rather than at a low amount increased slowly (Jonklaas et al., 2014). For her weight, that gives a weight-based composite starting amount near the full replacement range. An older patient, or one with coronary disease, would start at a lower amount and increase it slowly, because restoring thyroid hormone raises heart rate and myocardial oxygen demand, which could provoke angina or arrhythmia.
A Week-Long Half-Life and a Six-Week Wait
Levothyroxine has a half-life of about seven days. A drug reaches steady state after four to five half-lives, so after any change in amount, about five to six weeks pass before the TSH reflects the full effect. TSH also responds slowly because the pituitary adjusts gradually. Checking the TSH at two weeks would show a value still moving and could lead to an unnecessary change. Her first recheck is therefore scheduled at six weeks, and every later change will be followed by the same wait.
Five Points in Plain Language
She received five teaching points in writing and aloud. 1. Take your pill at the same time every day, first thing in the morning. 2. Take it with water on an empty stomach, and wait 30 to 60 minutes before eating or drinking coffee. 3. Keep it four hours away from calcium, iron or antacids, including vitamins that contain them. 4. If you miss a pill, take it when you remember that day; if you remember the next day, you can take two that day. 5. Call if you feel your heart racing, feel shaky or cannot sleep, because those can mean the amount is too high.
Follow-Up: Two TSH Results
At six weeks her TSH had fallen to 6.4 mIU/L, and her fatigue was a little better. The trend was right, but the value was still above the range, so the amount was increased by about 12 to 25 mcg per day, a common adjustment step, with another recheck in six weeks.
At twelve weeks, despite the higher amount, her TSH had risen to 7.9 mIU/L. Raising the amount again without asking why would be the wrong response. On review, she explained that her gynecologist had recommended calcium carbonate 600 mg twice daily after she mentioned her periods had stopped, and she had been taking the first tablet with her levothyroxine at breakfast. Calcium carbonate binds levothyroxine in the gut and reduces its absorption; in one study it raised TSH significantly over three months (Singh et al., 2000). Teaching point 3 had been given, but she had not connected "calcium" on her teaching sheet with the supplement a different clinician recommended later.
The response is to separate the doses by at least four hours, moving calcium to lunch and dinner, and to recheck TSH in six weeks without changing the levothyroxine amount, since the second increase may already be enough once absorption is restored.
Reflection
The second TSH shows that teaching is not complete when it is delivered. She understood the calcium point at the first visit, but the supplement came from a different clinician months later. In future I would ask about new supplements and new prescribers at every follow-up visit and would give written teaching that names common products, such as calcium chews and multivitamins, rather than the word calcium alone. I would also send a short note to the clinician who recommended the supplement, so that the timing advice travels with the prescription. The case also shows the value of defining success before treatment: because a TSH within range had been named as the target, a rise at twelve weeks was recognized at once as a failure to explain rather than a number to chase. Finally, her symptoms will be reviewed alongside the TSH at the next visit, since some fatigue after menopause may persist even when the thyroid value is corrected, and she should know that in advance.
References
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017). Hypothyroidism. The Lancet, 390(10101), 1550-1562. https://doi.org/10.1016/S0140-6736(17)30703-1
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., & Sawka, A. M. (2014). Guidelines for the treatment of hypothyroidism: Prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid, 24(12), 1670-1751. https://doi.org/10.1089/thy.2014.0028
Singh, N., Singh, P. N., & Hershman, J. M. (2000). Effect of calcium carbonate on the absorption of levothyroxine. JAMA, 283(21), 2822-2825. https://doi.org/10.1001/jama.283.21.2822
How this MN553 Unit 10 example is structured
The case is organized around one question, evidence of effect, and every earlier section is written so that the follow-up can test it. Selection names what would count as success before any tablet is described: TSH back within the reference range and symptoms improving over two to three months. The half-life of about a week sets the rhythm of the whole analysis, since roughly six weeks pass before a change in amount shows its full effect, and the case explains why checking sooner would mislead. Education is written in plain language and kept to five points: the same time each day, an empty stomach, distance from calcium or iron, a plan for a missed tablet, and symptoms to report. The follow-up section then reads the second TSH against that teaching and finds where it did not hold.
Get an MN553 Unit 10 example written to your instructions
Everything the Unit 10 case in your MN553 section supplies, history, labs, follow-up data and the rubric, can come in as it is. A first sample arrives free within 24-48h, joining selection, patient teaching and follow-up into one argument, with any amount bracketed and the recheck timing tied to the drug's kinetics. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN553 Unit 10 questions, answered
How long should the selection section be compared with the others?
Often the longest, but not by much. Selection carries the pharmacology, yet a case analysis in a final unit usually weights the teaching and monitoring sections about as heavily. A useful check is whether each section could stand alone: if follow-up only repeats the plan, it has not tested anything, and the case reads as a longer version of an earlier assignment.
What if the follow-up data in my case look normal?
Then the follow-up section still has work to do. It should say what the normal result confirms, whether the timing of the check was right for the drug, and what would prompt the next review. A normal value interpreted against the goal set at selection is evidence of effect; a normal value simply reported is not.
Should the analysis discuss combination T4 and T3 therapy?
Briefly, if the case or prompt raises it. Some patients remain symptomatic despite a normal TSH and ask about it, and the literature has continued to debate the question since the 2014 guideline. A short, dated paragraph that states the current guideline position and the ongoing research shows awareness without turning the case into a review.